Focused Ultrasound Trials Targeted Cancer Treatment
Researchers are testing how sound waves can destroy tumors that are difficult to reach with conventional surgery.
Updated on Sept. 19, 2026 in Cancer
Live Poll
Should experimental medical technologies be available to patients before large-scale clinical trials are completed?
Clinical trials for focused ultrasound, a method that uses precise acoustic energy to destroy tissue, are currently investigating new ways to treat pancreatic and brain cancers. In April 2026, Gleneagles Hospital in Hong Kong performed its first two histotripsy procedures for pancreatic cancer as part of this ongoing effort.
Why it matters
This technology aims to manage complex tumors that remain challenging for surgeons to access through traditional operations. As research expands to 196 potential medical applications, these advancements could provide new treatment options for patients with limited alternatives.
There are 196 potential medical applications currently being researched, with 12 indications entering first-in-human clinical trials. While over 1 million patients have received some form of focused ultrasound historically, the efficacy of histotripsy for specific cancers remains under investigation.
The players
Focused Ultrasound Foundation
A U.S.-based organization that accelerates the development and adoption of focused ultrasound technology for various medical conditions.
Gleneagles Hospital
A healthcare facility in Hong Kong that is currently conducting clinical trials for focused ultrasound histotripsy procedures.
The details
Focused ultrasound technology works by directing multiple beams of acoustic energy at a precise internal target. When used in histotripsy, these beams create mechanical forces that physically destroy tumor tissue without requiring an incision. Researchers are currently evaluating this mechanism to see if it can successfully modulate brain circuits or eliminate malignant cells in areas difficult to reach via standard surgical techniques.
Timeline
2006: The Focused Ultrasound Foundation was founded.
2025: Nearly 75,000 patients received focused ultrasound treatment.
April 2026: Gleneagles Hospital performed first pancreatic cancer clinical trials.
Within 3 years: Expected results from pancreatic and brain cancer trials.
Within 5 years: Projected increase of ultrasound systems to 10,000.
Health Landscape
The clinical use of focused ultrasound is currently undergoing a period of rapid scaling, moving from niche applications to potential standard-of-care status for complex tumors. This evolution reflects a broader trend of shifting toward non-invasive, energy-based surgical alternatives.
Because these treatments are currently in clinical trials, they are not yet widely available as a standard alternative to surgery. Patients interested in emerging options for difficult-to-treat tumors should discuss current trial eligibility and assessment requirements with an oncologist.
The takeaway
Focused ultrasound is a growing field that uses acoustic energy to target and destroy tissue without traditional surgery. Patients with complex diagnoses can monitor clinical trial registries for updates on whether these non-invasive techniques become applicable to their specific treatment needs.
Further reading
Learn more about the latest innovations in Cancer care and research.
Live Poll
Should experimental medical technologies be available to patients before large-scale clinical trials are completed?
